Trimetazidine attenuates the acute inflammatory response induced by Novolimus eluting bioresorbable coronary scaffold implantation. [electronic resource]
Producer: 20170829Description: 514-9 p. digitalISSN:- 1874-1754
- Absorbable Implants -- adverse effects
- Adult
- Aged
- Coronary Vessels -- drug effects
- Drug-Eluting Stents -- adverse effects
- Female
- Humans
- Inflammation -- blood
- Inflammation Mediators -- blood
- Macrolides -- adverse effects
- Male
- Middle Aged
- Percutaneous Coronary Intervention -- adverse effects
- Single-Blind Method
- Tissue Scaffolds -- adverse effects
- Trimetazidine -- administration & dosage
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.